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z.2013.07Abstract Alloxan has been widely used to produce experimental diabetes mellitus syndrome. This
study was undertaken to investigate the protective effect against alloxan-induced pancreatic damage
by curcumin. Rats were divided into four groups. (1) Control group. (2) Curcumin control group.
(3) Diabetic group with a single intraperitoneal injection of 100 mg alloxan/kg b.wt. (4) Diabetic
group treated with curcumin orally at a dose of 60 mg/kg b.wt dissolved in distilled water. Blood
samples were collected for the detection of serum glucose levels. The pancreas was prepared for his-
topathological, immunohistochemical stain using anti-insulin antibody and ultrastructural studies.
The electron microscopic examination of diabetic pancreas showed marked changes in pancreatic
acini represented by dilated rough endoplasmic reticulum, decrease of secretory granules, cytoplas-
mic vacuolation and irregular contours of nuclei. b-Cells showed fusion of some granules, obvious
vacuolation and pyknotic nuclei. a Cells revealed focal necrosis and vacuolation, dilated rough
endoplasmic reticulum and depletion of secretory granules. Curcumin improved the histopathology
and ultrastructure changes of the islets, alpha cells and exocrine acini, which nearly reverted to their
normal structure. It increased insulin immunoreactivity and decreased the elevated glucose concen-
trations.
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.003Introduction
The World Health Organization (WHO) estimates that more
than 220 million people worldwide have diabetes, and this
number is liable to double by 2030 (Setacci et al., 2009;
WHO, 2009). Diabetes is a disease in which the hallmark
feature is elevated blood glucose concentrations due to a
loss of insulin-producing pancreatic b-cells (type 1 diabetes)
or through loss of insulin responsiveness in its target tissues
like adipose and muscle (type 2 diabetes) (Schwarz et al.,
2009). It affects 5% of the world population and becomeshe Egyptian German Society for Zoology.
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disease (Taylor, 1999). Alloxan has been widely used to pro-
duce experimental diabetes mellitus syndrome. It causes
necrosis of pancreatic b-cells and induces free radicals which
play a relevant role in the etiology and pathogenesis of both
experimental and human diabetes mellitus (Soto et al.,
2004). Moreover, widespread lipoid deposits throughout
the exocrine tissue, and loss of b cells (Soto et al., 2004).
It has been suggested that alloxan induces the production
of H2O2 and of some free radicals such as O2 and OH
which produce cellular damage followed by cell death.
Therefore, alloxan was considered adequate for the study
of pathology of diabetes mellitus (Winterbourn and
Munday, 1989; Soto et al., 1994). Alloxan selectively and
rapidly accumulates in b-cell (Gorus et al., 1982) and it
affects directly or indirectly on the membrane potential
and ion channels in b-cells (Carroll et al., 1994). The induc-
tion of reactive oxygen species seems to be the mechanism
by which alloxan damages the b-cells (Sentman et al.,
1999). Alloxan potentially damages the pancreatic b-cells,
because the antioxidant competencies are very low than that
of other tissues (Tiedge et al., 1997). Therefore, they are pre-
dominantly vulnerable to oxidative stress resulting in the
suppression of insulin gene transcription, glucose-stimulated
insulin secretion and even producing apoptosis (Kaneto
et al., 2001). Little is known about the effect of alloxan
on a cells. It has been assumed that alloxan toxicity is rela-
tively speciﬁc for the b-cell. However, since the physico-
chemical characteristics of the glucose recognition sites are
considered to be similar in a- and b-cells, it was felt logical
to investigate whether the a-cell might also be susceptible to
alloxan poisoning (Pagliara et al., 1977). Aleeva et al. (2002)
reported that alloxan decreased the count of insulin-
producing b-cells, but increased the number of glucagon-
secreting a-cells in the pancreas (week 1 of diabetes).
Moreover, immunohistochemical and morphometric investi-
gation showed that antidiabetic effect of an organic
derivative of vanadium (IV) produced a reliable increase in
the population of insulin-producing cells and a decrease in
the (alloxane-enhanced) population of a-cells in the pancre-
atic islands (Aleeva et al., 2004).
Plants with anti-diabetic activities provide useful sources
for the development of drugs in the treatment of diabetes mel-
litus. Phytochemicals isolated from plant source are used for
the prevention and treatment of cancer, heart disease, diabetes,
high blood pressure etc. (Mary et al., 2002).
Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-hept-
adiene-3,5-dione), the active portion of turmeric, has been
shown to have signiﬁcant antioxidant activity, both in vitro
and in vivo (Joe et al., 2004), curcumin is a potent scavenger
of reactive oxygen and nitrogen species such as hydroxyl rad-
icals and nitrogen dioxide radicals (Reddy and Lokesh, 1994).
In addition curcumin has various other health-beneﬁting prop-
erties, such as anti-diabetic, antioxidants, anti-inﬂammatory,
anticarcinogenic, antiviral, hypolipidemic, and anti-infectious
effects (Araujo and Leon, 2001; Miller et al., 2001 and
Aggarwal et al., 2003). A broad body of evidence indicates that
curcumin has a potential hypoglycemic effect in experimental
diabetic animal models (Pari and Murugan, 2005). Moreover,
the use of curcumin is recommended for the prevention of
advanced glycated endproduct (AGE) accumulation and the
associated complications of diabetes (Sajithlal et al., 1998).This study aims to investigate the effect of alloxan on ultra-
structures of a cells since little studies were found. Further-
more, it displays the hypoglycemic effects of curcumin in the
treatment of diabetes.
Materials and methods
Chemicals
All chemicals and reagents used in the present study were ob-
tained from Sigma–Aldrich Inc. (St. Louis, MO).
Animals and experimental design
Thirty-two adult male albino rats (Rattus norvegicus) of similar
age (3–4 months) and weight 130–180 g (obtained from the
animal house of Research Institute of Opthalmology, El-Giza,
Egypt) were used in the present study. All animals were kept
under observation for about 10 days before the onset of the
experiment to exclude any intercurrent infection. The chosen
animals were housed in individual cages in a temperature-
and humidity-controlled room with a 12-h light–dark cycle.
All the animals had free access to water and supplied daily
with a standard pellet diet. All animals included in the present
study were handled and received humane care in compliance
with the principles of laboratory animal care. All protocols
for their use in this investigation were approved by the Beni-
Suef University.
Animals were made diabetic with a single intraperitoneal
injection of 100 mg alloxan/kg body weight in 0.1 M phos-
phate citrate buffer, pH 4 (Gold, 1970).
Rats were identiﬁed as diabetic on the basis of blood glu-
cose levels (ranging from 180 to 300 mg/dl at least 7 days
post-alloxan treatment). Thirty-two rats were divided into four
groups (8 rats in each group) as required by the experiment.
The ﬁrst group was regarded as normal animals which were
kept without treatment under the same laboratory condition
and regarded as the franc control group for diabetic one.
The second group was made diabetic with a single intraperito-
neal injection of 100 mg alloxan/kg body weight. The third one
was treated with curcumin at a dose of 60 mg/kg b.wt dis-
solved in distilled water (Sharma et al., 2006). Treatment with
curcumin was performed orally by gastric intubation and daily
between 8.00 and 10.00 a.m. for 2 months.
For biochemical analyses, the animals of all tested groups
were sacriﬁced under diethyl ether anesthesia at the end of
2 months. Blood samples were collected from each rat. It
was allowed to coagulate at room temperature and centrifuged
at 3000 rpm for 30 min.
Biochemical studies
Glucose test was performed on rats of all tested groups at the
end of the experiment. Blood samples were obtained from lat-
eral tail vein of overnight fasted rats (10–12 h). Successive
blood samples were then taken at 30, 60, 90 and 120 min fol-
lowing the oral administration of glucose solution (3 g/kg b.
wt.). Serum was then separated for the determination of glu-
cose concentration according to the method of Siest and Schie-
lef (1981), using reagent kits purchased from Bio Merieux
chemicals (France).
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After 2 months the animals were dissected. The pancreas were
removed then ﬁxed in 10% neutral buffered formalin for 24 h;
the organs were routinely processed and sectioned at 4–5 m
thickness. Sections of pancreas were stained with Masson tri-
chrome stain (Drury et al., 1976) to demonstrate collagen ﬁ-
bers and also stained with the modiﬁed aldehyde fuchsin
method (Bancroft and Stevens, 1982).Immunohistochemistry of pancreatic islets
Immunolocalization technique for anti-insulin was performed
on 5–6 m thickness sections and stained with the streptavi-Table 1 serum glucose concentration values of control, alloxan dia
fasting and 2 h.
Parameter Group
Control Dia
Fasting 79.443 ± 2.848e 144
After 2 h 107,161.255 ± 5.540d 262
LSD at 5% level is: 13.942.
LSD at 1% level is: 18.776.
Data are expressed (6 rats in each group) as Mean ± SE.
Values, which not share the same superscript symbol within a row, are s
LSD= Least Signiﬁcant Difference.
Fig. 1 Aldehyde fuchsin. (a–d photomicrograph section of rat panc
pancreatic acini. The acini are formed of pyramidal cells with basal nu
embedded within the exocrine portions (E) and alpha cells (arrows) l
curcumin showing nearly normal structure of Islets of Langerhans
pyramidal cells with basal nuclei (arrows). (c) Diabetic rats revealed
pancreas represented by vacuolation (v) and marked decrease of b-cells
cytoplasmic vacuolation and pyknotic nuclei of some acinar cells. (d) A
to the control and most of the island of Langerhans (I) cells were intadin–biotin–peroxidase staining method (Cemek et al., 2008).
Parafﬁn sections were deparafﬁnized in xylene, rehydrated in
descending grades of alcohol. Endogenous peroxidase and
non-speciﬁc binding sites for antibodies were suppressed by
treating the sections with 0.3% hydrogen peroxide for
20 min and 5% normal bovine serum (1:5 diluted TRIS) for
20 min at room temperature, respectively. The sections were
washed in phosphate buffered saline and 10% normal goat ser-
um was applied for 30 min to reduce non-speciﬁc binding. The
sections were incubated for 1 h with anti-sera containing pri-
mary antibodies for rat insulin (polyclonal antibody) supplied
by Bio Genex Cat. No. AR. 295-R. The sections were incu-
bated with biotinylated secondary antibody (Dako-K0690;
Dako Universal LSAB Kit) and streptavidin horseradish
peroxidase (Dako-K0690) for 30 min, and then 3,30-diam-betic and diabetic rats treated with curcumin for 2 months after
betic Diabetic rats treated with curcumin
.960 ± 3.180c 110.468 ± 5.589d
.202 ± 3.901a 160.982 ± 6.784b
igniﬁcantly different.
reas. (a) Control rat pancreas showing closely packed lobules of
clei and apical acidophilic cytoplasm. Islets of Langerhans (I) were
ocated on the peripher. (b) Control pancreas of rats treated with
(I) embedded within the exocrine portions which are formed of
pathological changes of both exocrine and endocrine part of the
. Some exocrine acini revealed focal acinar damage represented by
fter supplementation with curumin the pancreas appeared similar
ct with no alteration except few vacuoles (H & E; ·100).
Fig. 2 Masson trichrome stains. Photomicrograph section of rat
pancreas showing (a and b) control pancreas showed delicate
collagen ﬁbers around islands of Langerhans islets of Langerhans
(I), delicate collagen ﬁbers around the pancreatic acini (arrows)
and blood vessels (v). (c–e) Diabetic pancreas showing. (c)
Atrophy in the islands of Langerhans cells (arrow heads)
associated with dense collagen ﬁbers around the acini (arrows).
(d and e) Thickening and hypertrophy were detected in the media
with swelling in the endothelium of the intima of the congested
stromal blood vessels (V) surrounded by collagen (C), dense
collagen ﬁbers around the acini (arrows) with some vacuoles
(arrow heads). (f and g) Treatment with curcumin showed few
collagen ﬁbers around the islets (I), blood vessels (v) and
pancreatic acini compared with the diabetic group. (Masson
trichrome; ·100.)
172 M. Abdul-Hamid, N. Moustafainobenzidine tetrahydrochloride (Sigma-D5905; Sigma–
Aldrich Company Ltd., Gillingham, UK) substrate kit for
10 min to obtain immunolabelling. Finally, the nuclei were
(i) stained using Harry’s hematoxylin stain, (ii) dehydrated
in graded alcohol, (iii) cleared in xylene, and then (iv)
mounted in DPX. The binding of antibodies was evaluated
by examination under high-power light microscopy. All sec-
tions were incubated under the same conditions with the
same concentration of antibodies and at the same time, so
the immunostaining was comparable among the different
experimental groups.
Ultrastructural preparations
After 2 months specimens were taken from the pancreas of all
groups. Thin sections for transmission electron microscopy
were prepared according to the method of Louis and Williams
(1995). Brieﬂy, 1–3 mm segment of pancreas were ﬁxed in fresh
3% glutaraldehyde–formaldehyde at 4 C for 18–24 h. The
specimens were then washed in phosphate buffer (pH 7.4)
and post-ﬁxed in isotonic 1% osmium tetroxide for 1 h at
4 C and then processed. Semithin sections (1 lm) were stained
with toluidine blue. Ultrathin sections (70–80 nm) were stained
with uranyl acetate and lead citrate and examined on a Joel
CX 100 transmission electron microscope operated at an accel-
erating voltage of 60 kV, Faculty of Science, Ain Shams
University.
Statistical analysis
The data were analyzed using one-way analysis of variance
(ANOVA) (PC-STAT, 1995) followed by least signiﬁcant dif-
ference (LSD) analysis to compare various groups with each
other. Results were expressed as mean ± standard deviation
and values of P> 0.05 were considered statistically, non-sig-
niﬁcantly different, while those of P< 0.05 and P< 0.01 were
statistically signiﬁcantly and highly signiﬁcantly different,
respectively.
Results
Biochemical results
Serum glucose
Diabetic rats showed a signiﬁcant increase in fasting
144.960 ± 3.180 mg/dl and postprandial glucose concentra-
tion 262.202 ± 3.901 mg/dl after 2 months as compared with
the control group. The present data revealed that daily admin-
istration of curcumin for 2 months caused marked hypoglyce-
mic effects on fasted 110.468 ± 5.589 mg/dl and postprandial
glucose level 160.982 ± 6.784 mg/dl as compared with the dia-
betic control group (Table 1).
Light microscopic results
Aldehyde fuchsin stain
The histological structure of the control pancreas consisted of
closely packed lobules of pancreatic acini. The acini are
formed of pyramidal cells with basal nuclei and apical acido-
philic cytoplasm. Islets of Langerhans were embedded within
Fig. 3 Immunohistochemistry. Photomicrographs of immunohistochemical staining of insulin in pancreatic islets of rats. (a) Control
group showing pancreatic b-cells with positive immunostaining which are distributed over the center of pancreatic islets and stained with
deep brown color. (b) Control curcumin group of pancreatic b-cells showed positive immunostaining with deep brown color similar to the
control. (c) Diabetic group showing signiﬁcant decrease of the immunostaining particles for insulin. (d) Diabetic rats treated with
curcumin, showing an increase in the staining particles. (Immunostaining for anti-insulin antibodies. ·400.)
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(Fig. 1a). Control pancreas of rats treated with curcumin
showing nearly normal structure of Islets of Langerhans (I)
embedded within the exocrine portions which are formed of
pyramidal cells with basal nuclei (Fig. 1b).
The present light microscopic study of diabetic rats revealed
pathological changes of both exocrine and endocrine part of
the pancreas represented by vacuolation and marked decrease
of b-cells. Some exocrine acini revealed focal acinar damage
represented by cytoplasmic vacuolation and pyknotic nuclei
of some acinar cells (Fig. 1c).
After supplementation with curcumin the pancreas ap-
peared similar to the control and most of the island of Langer-
hans were intact with no alteration except few vacuoles
(Fig. 1d).
Masson trichrome stains
By Masson trichrome stains, the control pancreas showed del-
icate collagen ﬁbers around the pancreatic acini, islands of
Langerhans and blood vessels (Fig. 2a and b).
Diabetic pancreas showed atrophy in the islands of
Langerhans cells associated with dense collagen ﬁbers aroundthe acini (Fig. 2c). Thickening and hypertrophy were detected
in the media with swelling in the endothelium of the intima of
the congested stromal blood vessels surrounded by collagen,
dense collagen ﬁbers around the acini with some vacuoles
(Fig. 2d and e).
Treatment with curcumin showed few collagen ﬁbers
around the islets, blood vessels and pancreatic acini compared
with the diabetic group (Fig. 2f and g).
Immunohistochemical results
Immunohistochemically, b-cells of the control group stained
with strong positive reaction for anti-insulin antibodies as
brown granules occupying the cytoplasm of great numbers of
the b-cells (Fig. 3a). Control curcumin group of pancreatic
b-cells showed positive immunostaining with deep brown color
similar to the control (Fig. 3b). In diabetic group, the immuno-
reactivity for anti-insulin antibodies was markedly decreased
in number of insulin positive cells (Fig. 3c). After treatment
with curcumin, positive immunoreactions of b-cells for anti-
insulin antibodies were obviously increased in numbers
(Fig. 3d).
Fig. 4 Exocrine part. Electron micrograph of rat pancreas showing (a) control acinar cells with euchromatic nuclei (N), well-developed
cisternae of rough endoplasmic reticulum (arrow heads), mitochondria and numerous electron dense secretory granules (arrows) of
variable sizes in the apical part. Scale bar = 1 lm. 4b and c): Electron micrograph of alloxan-diabetic rat pancreas showing (b) Marked
changes in pancreatic acini represented by damaged mitochondria (M), dilated rough endoplasmic reticulum, decrease of secretory
granules (arrows) and cytoplasmic vacuolation. Scale bar = 2 lm. (c) Damaged mitochondria (M), auotophagic vacuole (arrow head),
dilated rough endoplasmic reticulum (arrows) and irregular contours of nuclei. Scale bar = 1 lm. (d) Diabetic rat pancreas treated with
curcumin showing marked improvement represented by increase in zymogen granules, regular contours of nuclei (N) and ﬂattened rough
endoplasmic (arrow heads) except few vacuoles. Scale bar = 1 lm.
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Acinar cells
Ultrastructure of control pancreas showed acinar cells with
euchromatic nuclei, well-developed cisternae of rough endo-
plasmic reticulum, mitochondria and numerous electron dense
secretory granules of variable sizes in the apical part (Fig. 4a).
Electron microscopic examination of the diabetic group
showed marked changes in pancreatic acini represented by di-
lated rough endoplasmic reticulum, decrease of secretory gran-
ules, cytoplasmic vacuolation, damaged mitochondria,auotophagic vacoule and irregular contours of nuclei
(Fig. 4b and c).
Pancreatic acini after supplementation with curcumin
showed marked improvement represented by increase in
zymogen granules, regular contours of nuclei and ﬂattened
rough endoplasmic reticulum except few vacuoles
(Fig. 4d).
b-Cells
Islets of Langerhans of control rats were formed mainly of
b-cells. Their cytoplasm contains numerous electron dense
Fig. 5 Beta cells. Electron micrograph of rat pancreas showing (a and b) control Islets of Langerhans were formed mainly of b-cells.
Their cytoplasm contains numerous electron dense secretory granules surrounded by wide lucent halo (arrow), mitochondria (arrow
head), Golgi apparatus (G) and euchromatic nucleus (N). Scale bar = 2.1 lm respectively. (c) Alloxan-diabetic rat pancreas showing b-
cells of diabetic rats with obvious vacuolation and decrease of secretory granules, fusion of some granules (F) and pyknotic nuclei (N).
Scale bar = 2 lm. (d) Electron micrograph of diabetic rat pancreas treated with curcumin showing euchromatic nucleus (N), few vacuoles
in b-cells and increase of secretory granules (arrows) compared to the diabetic one appeared nearly similar to the control group. Scale
bar = 1 lm.
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dria, Golgi apparatus and euchromatic nucleus (Fig. 5a and b).
b-Cells of diabetic rats showed obvious vacuolation and de-
crease of secretory granules, fusion of some granules and pyk-
notic nuclei (Fig. 5c)
Treatment with curcumin revealed euchromatic nucleus,
few vacuoles in b-cells and increase of secretory granules com-
pared to the diabetic ones (Fig. 5d).
a-Cells
In the control a cells, the cytoplasm appeared with numerous
secretory granules of electron dense core and surrounded by
narrow halo, mitochondria and round euchromatic nucleus
(Fig. 6a and b).a cells of the diabetic group revealed focal necrosis
and vacuolation, dilated rough endoplasmic reticulum,
depletion of secretory granules and pyknotic nuclei
(Fig. 6c and d).
Supplementation with curcumin resulted in obvious
improvement in the ultrastructure of a-cells including increase
of zymogen granules (Fig. 6e).
Discussion
The present diabetic rats showed a signiﬁcant increase in fast-
ing and postprandial glucose concentration compared with the
control group. This result is in agreement with Dahecha et al.
(2011) and Ramar et al. (2012).
Fig. 6 Alpha cells. Electron micrograph of rat pancreas showing (a) the cytoplasm of control a cells with numerous secretory granules
(arrows) of electron dense core and surrounded by narrow halo. Notice the round euchromatic nucleus (N). Scale bar = 2 lm. (b)
Mitochondria (arrows) of control a cells and numerous secretory granules (arrow head). Scale bar = 1 lm. (c and d) Alloxan-diabetic rat
pancreas showing a cells of diabetic group revealed focal necrosis and vacuolation (V), dilated rough endoplasmic reticulum, depletion of
secretory granules and pyknotic nuclei (N). Scale bar = 2.1 lm respectively. (e) Diabetic rat pancreas treated with curcumin showing
obvious improvement in the ultrastructure of a-cells including increase of zymogen granules which appeared nearly similar to the control
group. Scale bar = 2 lm.
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ported by Peeyush et al. (2009), El-Moselhy et al.
(2011). Moreover, curcumin antagonizes the deﬁcit of glu-cose energy metabolism or oxidative stress related to cog-
nitive impairment associated with diabetes. (Shishodia
et al., 2005).
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alloxan injection represented by destructed b-cells and vacuo-
lated pancreatic acini. Similar results were observed by Jelodar
et al. (2005) and Hamden et al., (2009). Moreover, alloxan
administration elicited signiﬁcant morphological changes in
diabetic rats with severe injury of pancreatic b-cells, such as
decreasing the islets cell numbers, cell damage, and cell death
(Dahecha et al., 2011). The thickened and hyalinized blood
vessels causing not enough oxygen reach the tissue which re-
sulted in degenerative changes and necrosis. (Pushparaj
et al., 2000).
The present immunoreactivity for anti-insulin antibodies
was markedly decreased in number of insulin positive cells
after alloxan injection. Me´ndez and Haro Herna´ndez (2005),
Ao et al. (2008) and Simsek et al. (2012) reported similar re-
sults. Furthermore, alloxan selectively destroyed and rapidly
accumulates in b-cell (Gorus et al., 1982; Jelodar et al.,
2005). Alloxan experimental models of pancreatic damage
have been demonstrated with structural and functional altera-
tions such as disorganization of pancreatic architecture, and
depletion of insulin producing cells (Davidson et al., 1989;
Waguri et al., 1997; Hashemi et al., 2009). The cytotoxic action
of alloxan is mediated by reactive oxygen species, with a simul-
taneous massive increase in cytosolic calcium concentration
leading to rapid destruction of b-cells (Szkudelski, 2001). In
the present study after treatment with curcumin, positive
immunoreactions of b-cells for anti-insulin antibodies were
obviously increased in numbers. Previous reports showed that
curcumin increases plasma insulin level in diabetic mice (Seo
et al., 2008) and in diabetic rat (Peeyush et al., 2009). Further-
more, the previous results of immunohistochemical and mor-
phometric investigation showed that antidiabetic effect of
organic derivative of vanadium (IV) oxide produced a reliable
increase in the population of insulin-producing cells (Aleeva
et al., 2004).
It has been found that oxidative stress is associated with the
molecular mechanism of the decreased insulin biosynthesis and
secretion, which is the main etiology of glucose toxicity. In-
deed, it was suggested that the pancreas may be more suscep-
tible to oxidative stress than other tissues and organs, because
pancreatic islet cells show extremely weak manifestation of
antioxidative enzymes (Evans et al., 2003; Robertson, 2006).
It is evident that oxidative stress plays a key role in causing
insulin resistance and b-cell dysfunction by their ability to acti-
vate stress-sensitive signaling pathways (Evans et al., 2003).
Increases in intracellular glucose lead to an abundance of
electron donors generated in the Kreb’s cycle which drive the
inner mitochondrial membrane potential upward, a state that
is associated with mitochondrial dysfunction and increased
ROS production (Korshunov et al., 1997).
The present ultrastructural study of the diabetic group
showed marked changes in pancreatic acini represented by di-
lated rough endoplasmic reticulum, decrease of secretory gran-
ules, cytoplasmic vacuolation, damaged mitochondria.
Moreover, b-cells and a cells showed obvious vacuolation
and decrease of secretory granules and pyknotic nuclei. Allox-
an, like glucose, affects a- and b-cells directly, stimulating the
b-cell and inhibiting the a-cell. So alloxan might have direct
toxic actions on both cell types, transiently stimulating and
then permanently blocking the b-cells and irreversibly inhibit-
ing the a-cells (Pagliara et al., 1977).Degirmenci et al. (2005) reported a decrease in secretory
granules of b-cells, vacuolization and swelling of mitochon-
dria. The semiquantitative evaluation of islet ultrastructure
after alloxan exposure in vitro demonstrated that mouse b-cells
showed signs of both necrotic and apoptotic cell death, distur-
bances in the insulin secretory pattern during and after an al-
loxan perfusion (Tyrberg et al., 2001). Alloxan induces damage
to b-cell DNA (Yamamoto et al., 1981), mitochondria (Bo-
quist and Ericsson, 1984), lysosomes (Zhang et al., 1992),
and plasma membrane (Watkins et al., 1964). Bogolepov
(1983) stated that vacuolation was one of the structural indica-
tions of permeability disorders of the membranes, which re-
sults in an enhanced transport of water and electrocytes into
the cell. The permeability disorder could be attributed to many
cellular membrane insults caused by reactive oxygen species
mediated formation of lipid peroxides, which ultimately gener-
ate self-sustaining lipid peroxidation (Halliwell and Chirico,
1993).
It has been reported that curcumin scavenges oxygen free
radicals and inhibits lipid peroxidation and protects cellular
macromolecules, including DNA from oxidative damage (Kal-
pana and Menon, 2004; Polasa et al., 2004). It is known to be a
multi-functional agent, such as powerful anti-oxidant, anti-
diabetic, anti inﬂammatory and anti-cancer agent (Miller
et al., 2001).
In conclusion, this study investigated the effect of alloxan
on a cells and threw light on the potential of curcumin in
the prevention or treatment of diabetes due to the importance
of human diabetes mellitus as a world health problem as well
as the increasing demand by patients to use the natural prod-
ucts with antidiabetic activity, because insulin and oral hypo-
glycemic drugs possess undesirable side effects. Further study
will be needed to study the effect of alloxan on a cells.
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